GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Planet 13 Holdings Inc (XCNQ:PLTH) » Definitions » Growth Rank

Planet 13 Holdings (XCNQ:PLTH) Growth Rank : 5 (As of Apr. 26, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Planet 13 Holdings Growth Rank?

Planet 13 Holdings has the Growth Rank of 5.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Competitive Comparison of Planet 13 Holdings's Growth Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Planet 13 Holdings's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Planet 13 Holdings's Growth Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Planet 13 Holdings's Growth Rank distribution charts can be found below:

* The bar in red indicates where Planet 13 Holdings's Growth Rank falls into.


;
;

Planet 13 Holdings Growth Rank Related Terms

Thank you for viewing the detailed overview of Planet 13 Holdings's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Planet 13 Holdings Business Description

Traded in Other Exchanges
Address
2548 West Desert Inn Road, Suite 100, Las Vegas, NV, USA, 89109
Planet 13 Holdings Inc a vertically integrated cultivator and provider of cannabis and cannabis-infused products in the States of Nevada and California, with retail cannabis operations in Illinois. The company currently sells over 154 different strains of cannabis and has a customer-loyalty database of over 385,000 customers. The company owns and manufactures cannabis products under the following brands: HaHa (gummies and beverages), Dreamland (chocolates), TRENDI (vapes and concentrates), Medizin (flower, vapes, concentrates), Leaf and Vine (vapes).
Executives
Christopher Brian Wren Senior Officer
Michael Denis Harman Director
Leighton Rudolph Koehler Senior Officer
Dennis Logan Senior Officer
Stephen Christopher Markle Senior Officer
William Joseph Vargas Senior Officer
Robert Allen Groesbeck 10% Security Holder, Director, Senior Officer
Larry Norman Scheffler 10% Security Holder, Director, Senior Officer
David Brandon Farris Senior Officer

Planet 13 Holdings Headlines

No Headlines